Strategies of statins for the prevention and treatment of hepatocellular carcinoma
10.3760/cma.j.cn501113-20231207-00269
- VernacularTitle:他汀类药物用于肝细胞癌防治的策略
- Author:
Ting TONG
1
;
Junfeng LI
;
Longzhen SHI
;
Liting ZHANG
Author Information
1. 兰州大学第一临床医学院，兰州 730000
- Publication Type:Journal Article
- Keywords:
Hepatocellular carcinoma;
Hydroxymethylglutaryl-CoA reductase inhibitors;
Therapeutic;
Drug therapy
- From:
Chinese Journal of Hepatology
2025;33(2):191-197
- CountryChina
- Language:Chinese
-
Abstract:
Hepatocellular carcinoma (HCC) is a kind of malignant tumor with an extremely high morbidity and mortality incidence rate. Although some new progress has been made in recent treatment, the overall prognosis is still poor. Therefore, the prevention and treatment of HCC have important clinical significance. Statin drugs are mainly used for the treatment of hypercholesterolemia and the prevention of cardiovascular and cerebrovascular diseases. In recent years, an increasing number of research results have shown that statins have advantages in preventing the occurrence and improving the prognosis of HCC. This paper reviews the new progress performed in the mechanism of statin drug and the current clinical prevention and treatment for HCC.
